{"title":"青年研究者专访CSCI杰出科学家奖获得者Michael Hill博士。","authors":"Wenxuan Wang, Michael D. Hill","doi":"10.25011/cim.v45i1.38099","DOIUrl":null,"url":null,"abstract":"Dr. Michael Hill is President of the Canadian Neurology Federation and Director of the Stroke Unit for the Calgary Stroke Program. He is also a professor at the University of Calgary at the Department of Clinical Neurosciences. Dr. Hill has made outstanding contributions to the field of stroke research, particularly through the ESCAPE and ESCAPE-NA1 trials. Dr. Hill was a recipient of the Canadian Society for Clinical Investigation (CSCI) Distinguished Scientist Award in 2021-recognized as an expert and innovative leader in his research.","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"3 1","pages":"E9-11"},"PeriodicalIF":1.2000,"publicationDate":"2022-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Young Investigator Interview With CSCI Distinguished Scientist Awardee Dr. Michael Hill.\",\"authors\":\"Wenxuan Wang, Michael D. Hill\",\"doi\":\"10.25011/cim.v45i1.38099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dr. Michael Hill is President of the Canadian Neurology Federation and Director of the Stroke Unit for the Calgary Stroke Program. He is also a professor at the University of Calgary at the Department of Clinical Neurosciences. Dr. Hill has made outstanding contributions to the field of stroke research, particularly through the ESCAPE and ESCAPE-NA1 trials. Dr. Hill was a recipient of the Canadian Society for Clinical Investigation (CSCI) Distinguished Scientist Award in 2021-recognized as an expert and innovative leader in his research.\",\"PeriodicalId\":50683,\"journal\":{\"name\":\"Clinical and Investigative Medicine\",\"volume\":\"3 1\",\"pages\":\"E9-11\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2022-03-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Investigative Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.25011/cim.v45i1.38099\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Investigative Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25011/cim.v45i1.38099","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
Michael Hill博士是加拿大神经病学联合会主席和卡尔加里中风项目中风部门主任。他也是卡尔加里大学临床神经科学系的教授。Hill博士在中风研究领域做出了杰出的贡献,特别是通过ESCAPE和ESCAPE- na1试验。Hill博士于2021年获得加拿大临床研究学会(CSCI)杰出科学家奖,被认为是他研究领域的专家和创新领导者。
Young Investigator Interview With CSCI Distinguished Scientist Awardee Dr. Michael Hill.
Dr. Michael Hill is President of the Canadian Neurology Federation and Director of the Stroke Unit for the Calgary Stroke Program. He is also a professor at the University of Calgary at the Department of Clinical Neurosciences. Dr. Hill has made outstanding contributions to the field of stroke research, particularly through the ESCAPE and ESCAPE-NA1 trials. Dr. Hill was a recipient of the Canadian Society for Clinical Investigation (CSCI) Distinguished Scientist Award in 2021-recognized as an expert and innovative leader in his research.
期刊介绍:
Clinical and Investigative Medicine (CIM), publishes original work in the field of Clinical Investigation. Original work includes clinical or laboratory investigations and clinical reports. Reviews include information for Continuing Medical Education (CME), narrative review articles, systematic reviews, and meta-analyses.